Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23969016 | 0.93 | PTGDR2 (0.40) | PTGDR2PDK2SIGMAR1HRH1FNTB | |
| SCHEMBL21917319 | 0.92 | PGR (0.31) | PGRPTGDR2 | |
| SCHEMBL21917288 | 0.91 | PTGDR2 (0.41) | PTGDR2PDK2SIGMAR1HRH1FNTB | |
| SCHEMBL23969000 | 0.91 | RXRA (0.45) | PGRRXRARXRGPTGDR2SIGMAR1 | |
| SCHEMBL21917690 | 0.86 | ALDH1A1 (0.38) | SIGMAR1HRH1FNTBKIF11TRPA1 | |
| SCHEMBL21917113 | 0.86 | PDE3B (0.37) | PDK2 | |
| SCHEMBL23969017 | 0.85 | KIF11 (0.30) | KIF11 | |
| SCHEMBL21917696 | 0.85 | RXRA (0.37) | RXRARXRGPTGDR2KIF11 | |
| SCHEMBL23968957 | 0.85 | PDE3B (0.37) | PTGDR2PDK2 | |
| SCHEMBL23968861 | 0.85 | ALDH1A1 (0.39) | SIGMAR1HRH1FNTBKIF11TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
| EP-3363782-B1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | PGR 1154/4885RXRA 585/4885RXRG 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.